-
Commentary – Biotech, Trump’s Latest Casino
If you thought the Trump administration couldn’t bungle any worse its response to the coronavirus pandemic, think again.
-
Tips for Running a Great Website
In the article, discover the top six tips for running a great website in 2020.
-
Infographic: Largest One-Day Dow Declines
Two of the six greatest one-day declines in the Dow-Jones Industrial Average since the year 2000 occurred last week, with the largest single-day drop on Thursday, nearly 10 percent.
-
Lilly, Biotech, NIH to Develop Covid-19 Antibodies
Drug maker Eli Lilly and Co., a biotechnology company, and an agency of NIH are collaborating on antibodies for novel coronavirus vaccines and therapies.
-
FDA Clears High-Volume Covid-19 Test
The Food and Drug Administration cleared for use in the U.S. a high-volume diagnostic for the novel coronavirus that can run on automated systems already in place.
-
Engineered Probiotic Maker Gains $2.3M Seed Funding
A developer of genetically-modified bacteria designed to work in the gut is raising $2.3 million more in seed funds to expand its product line.
-
Gates Funding Covid-19 Vaccine Delivery Device
A biotechnology company developing a vaccine for the Covid-19 virus received funding to scale up a delivery device for the vaccine when it’s available.
-
Start-Up Developing Marine Bio-Inspired Super Glue
A new enterprise is creating an strong binding adhesive inspired by mussels, derived from research in a university chemistry and materials science lab.
-
Engineered Viruses Deployed to Treat Gut Infections
Academic and industry researchers created gene-editing viruses that in lab cultures and mice killed bacteria causing often deadly intestinal infections.
-
Biotech Partners for A.I. Drug Discovery in $1B Deal
Two companies are collaborating on the use of artificial intelligence to find new drugs addressing a set of proteins that regulate immune-related functions, including inflammation.